About Clinical Research
Clinical research is a branch of healthcare science that determines the safety and effectiveness of medications, devices, diagnostic products and treatment regimens intended for human use. These may be used for prevention, treatment, diagnosis or for relieving symptoms of a disease.
Hunt is on to find more effective flu treatments
......
Ukraine war: Cannabis in focus for veterans treatment
... " We have to do Clinical Research, to get more convincing evidence that it works, " he says, " because we really are the global epicentre of PTSD...
Puberty blockers to be given only in clinical research
...By Lauren Moss, LGBT correspondent & Josh Parry, LGBT producerBBC NewsPuberty blockers will only be prescribed to children attending gender identity services as part of Clinical Research, NHS England has announced...
Breast cancer gene linked to Orkney islands
... Analysis by Laura Goodwin, BBC Scotland Science and Innovation CorrespondentIdentifying this variant - BRCA1 V1736A - is the result of 25 years of Clinical Research by Prof Zosia Miedzybrodzka, the director of the NHS Grampian Clinical Genetics service...
China's new human gene-editing rules worry experts
... Many scientists have wondered how Dr He could be allowed to return to Clinical Research after prison...
Type 1 diabetes trial to identify at-risk children
... Parth Narendran, professor of diabetes medicine, and Dr Lauren Quinn, Clinical Research fellow at the University of Birmingham, said there was a need to explore if screening children for type 1 diabetes in the UK would be possible in the UK...
Google helps Newport woman discover rare heart condition
... Dr Alice Jackson, who is leading the study based in Scotland, is a Clinical Research fellow at the University of Glasgow s Institute of Cardiovascular and Medical Sciences...
Coronavirus: a Tiger at the Bronx Zoo tests positive for Covid-19
... Sarah Caddy, veterinary surgeon and Clinical Research Fellow at the University of Cambridge, react among the experts on the reports...
Puberty blockers to be given only in clinical research
By Lauren Moss , LGBT correspondent & Josh Parry , LGBT producerBBC News
Puberty blockers will only be prescribed to children attending gender identity services as part of Clinical Research , Nhs England has announced.
The Move comes after into children's gender services said there were " gaps in evidence" around The drugs.
Blockers are used to " pause puberty" and work by supressing hormone release.
Dr Hilary Cass's report called for a transformation in The model of care for children with gender-related distress.
Currently, if a child seeks medical help, The drugs are one of The options a doctor could offer to help delay The Onset of physical changes that do not match a child's gender identity.
This change will come into effect when new clinics replacing The Gender Identity and Development Service (Gids) begin to open later this year. No patients being treated by The current Gids service will be affected.
Children and their families will also be " strongly discouraged" from obtaining gender-affirming drugs such as hormones, from " unregulated sources" or online providers.
A clinical study, run by The new Children and Young People 's Gender Dysphoria Research and Oversight Board, will look at The impact of drugs which delay puberty.
Further details on how The study will run will be released in The Coming weeks, but only those signed up to take part in The research will be prescribed puberty blockers, except in exceptional circumstances on a case-by-case basis.
It is expected that The study will mostly involve looking at patient data and records.
from Gids looked at a random selection of 312 patients in One Year and found 47 of them accessed hormone suppressants.
An NHS spokesperson said: " The NHS is today publishing an interim specification for gender services for children and Young People In Line with advice and recommendations from The Independent Cass Review - this will allow The new centres to finalise their preparation for service provision later this year.
" The NHS is now engaging on The Proposal that puberty blockers will not be made routinely available outside of research. We will develop a study into The impact of puberty blockers on gender dysphoria in children and Young People with early-onset gender dysphoria, which aims to be up and running in 2024. "
More Than 5,000 people responded to a consultation on The Last Year , and The new model will be implemented when The First of The new clinics opens in The South of England this autumn in partnerships with children's hospitals.
The current service, run by The Tavistock and Portman Trust, is to close in March 2024 following an carried out by Dr Cass - The paediatrician found The Service is " unsustainable" and said a new model of care is needed.
Dr Cass said many children referred to Gids have complex needs that can be sometimes overlooked and around a third have autism or other types of neurodiversity.
The NHS says a " significant proportion" of Young People with concerns related to their gender can also experience other complexities related to Mental Health , neuro-development and family or social matters.
The New Service will take a new " holistic" approach, focusing on The needs of each child individually with " careful therapeutic exploration".
It will be updated further after The Final report by Dr Cass is published.
In order to be prescribed puberty blockers on The NHS, a patient would currently need to first be assessed by Gids and referred to an endocrinologist.
More Than 7,000 Young People under The Age Of 18 are awaiting their first appointment, with The Waiting list thought to be More Than three and a half years long.
Related TopicsSource of news: bbc.com
